To the Editor: In September 2012, the Australian Institute of Health and Welfare (AIHW) released its report on cancer survival and prevalence in Australia from 1982 to 2010, incorporating incidence and mortality estimates for all malignancies reported to Australian cancer registries.1 Cancer is a leading cause of morbidity and mortality in Australia, accounting for about 20% of the total disease burden and 30% of deaths.2
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Australian Institute of Health and Welfare. Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Canberra: AIHW, 2012. (AIHW Cat. No. CAN 65.) http://www.aihw.gov.au/publication-detail/?id=10737422720 (accessed Oct 2012).
- 2. Australian Institute of Health and Welfare. Cancer in Australia 2010: an overview. Canberra: AIHW, 2010. (AIHW Cat. No. CAN 56.)
- 3. Carville KS, Cowie BC. Recognising the role of infection: preventing liver cancer in special populations. Cancer Forum 2012; 36: 23-26.
- 4. Robotin MC, Kansil M, Howard K, et al. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening. J Hepatol 2009; 50: 990-998.
- 5. Third National Hepatitis C Strategy 2010–2013. Canberra: Australian Government Department of Health and Ageing, 2010.
- 6. National Hepatitis B Strategy 2010–2013. Canberra: Australian Government Department of Health and Ageing, 2010.
No relevant disclosures.